Average Co-Inventor Count = 11.17
ph-index = 10
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Schering Corporation (14 from 1,829 patents)
2. Merck Sharp + Dohme Corp. (10 from 2,405 patents)
3. Dendreon Corporation (5 from 53 patents)
4. Pharmacopeia Drug Discovery, Inc. (3 from 52 patents)
5. Mochida Pharmaceutical Co., Ltd. (2 from 229 patents)
6. Pharmacopeia Inc. (1 from 101 patents)
7. Schering-Plough Corporation (1 from 28 patents)
25 patents:
1. 9695198 - Factor IXa inhibitors
2. 8987242 - Morpholinone compounds as factor IXA inhibitors
3. 8871929 - Fused-imidazoyl compounds useful as antimicrobial agents
4. 8765757 - 3-heterocyclic substituted indole derivatives and methods of use thereof
5. 8716312 - Inhibitors of diacylglycerol acyltransferase
6. 8673924 - Substituted pyrazolo[1,5-a]pyrimidines as cyclin dependent kinase inhibitors
7. 8642582 - Morpholinone compounds as factor IXa inhibitors
8. 8614229 - Substituted indole derivatives and methods of use thereof
9. 8609676 - 4, 5, 6-trisubstituted pyrimidine derivatives as factor IXa inhibitors
10. 8440443 - MEK1 polypeptides
11. 8148363 - Heterocyclic compounds as factor IXA inhibitors
12. RE43298 - Peptides as NS3-serine protease inhibitors of hepatitis C virus
13. 8143305 - 2,3-substituted indole derivatives for treating viral infections
14. 7884080 - Azetidinone derivatives and methods of use thereof
15. 7700601 - Substituted indazoles of formula 1.0 that are kinase inhibitors